• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

FXIIIA Positive Control

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS542778

Western Blot Positive Control Blood coagulation factor XIII a subunit Antibody N-epitopeFactor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains,… More details

$370 / 5 Applications +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
FXIIIA, Positive Control
Full Product Name
FXIIIA Antibody Western Blot Positive Control
Product Gene Name
Product Synonym Names
bA525O21.1 (coagulation factor XIII, A1 polypeptide); Coagulation factor XIII A chain; F13A; F13A1; Fibrin stabilizing factor, A subunit; Fibrinoligase; FSF, A subunit; FXIIIA; Protein-glutamine gamma-glutamyltransferase A chain; TGase; Transglutaminase A chain antibody
Form/Format
Western Blot Positive Control
Preparation and Storage
-20 degree C for long term storage
Matching Pairs
Antibody: Factor XIIIa (MBS540745)
Positive Control: FXIIIA (MBS542778)
Matching Pairs
Antibody: Factor XIIIa (MBS540856)
Positive Control: FXIIIA (MBS542778)
Molecular Weight
83,267 Da
OMIM
134570
3D Structure
ModBase 3D Structure for P00488
Immunogen
Purified Protein
Determinant
N-epitope
Molecular Function
Metal ion binding; Protein-glutamine gamma-glutamyltransferase activity
Structure
Tetramer of two A chains and two B chains.
Subcellular Location
Cytoplasm. Secreted
Applications Tested/Suitable for FXIIIA positive control
Western Blot (WB)
Application Notes for FXIIIA positive control
Western Blot: 1:500

Other Notes

Small volumes of FXIIIA positive control vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for FXIIIA purchase

MBS542778 is a positive control targeting FXIIIA. Also known as FXIIIA Antibody Western Blot Positive Control.

Additional Details

NCBI/Uniprot data below describe general gene information for FXIIIA. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
factor XIII a subunit
NCBI Official Synonym Full Names
coagulation factor XIII A chain
NCBI Official Symbol
F13A1
NCBI Official Synonym Symbols
F13A
UniProt Protein Name
Coagulation factor XIII A chain
UniProt Synonym Protein Names
Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain
UniProt Gene Name
F13A1
UniProt Synonym Gene Names
F13A; Coagulation factor XIIIa
UniProt Entry Name
F13A_HUMAN
NCBI Protein Information
coagulation factor XIII A chain

NCBI Summary for FXIIIA

This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
Show more

UniProt Comments for FXIIIA

F13A1: Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl- epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Defects in F13A1 are the cause of factor XIII subunit A deficiency (FA13AD). FA13AD is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. Belongs to the transglutaminase superfamily. Transglutaminase family.

Protein type: EC 2.3.2.13; Transferase

Chromosomal Location of Human Ortholog: 6p25.3-p24.3

Cellular Component: extracellular region

Molecular Function: metal ion binding; protein-glutamine gamma-glutamyltransferase activity

Biological Process: blood coagulation; peptide cross-linking; platelet degranulation

Disease: Factor Xiii, A Subunit, Deficiency Of; Myocardial Infarction, Susceptibility To; Thrombophilia Due To Thrombin Defect
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000